These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34031139)

  • 21. Human organic anion transporter 2 is an entecavir, but not tenofovir, transporter.
    Furihata T; Morio H; Zhu M; Suzuki Y; Ide H; Tsubota A; Fu Z; Anzai N; Chiba K
    Drug Metab Pharmacokinet; 2017 Feb; 32(1):116-119. PubMed ID: 27916488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimation of the Effect of OAT2-Mediated Active Uptake on Meloxicam Exposure in the Human Liver.
    Li R; Mathialagan S; Novak JJ; Eng H; Riccardi K; Litchfield J
    AAPS J; 2020 Jan; 22(2):20. PubMed ID: 31900711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. OAT2 catalyses efflux of glutamate and uptake of orotic acid.
    Fork C; Bauer T; Golz S; Geerts A; Weiland J; Del Turco D; Schömig E; Gründemann D
    Biochem J; 2011 Jun; 436(2):305-12. PubMed ID: 21446918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzoic acid and specific 2-oxo acids activate hepatic efflux of glutamate at OAT2.
    Pfennig T; Herrmann B; Bauer T; Schömig E; Gründemann D
    Biochim Biophys Acta; 2013 Feb; 1828(2):491-8. PubMed ID: 22981274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Hepatic Organic Anion Transporter 2 in the Pharmacokinetics of R- and S-Warfarin: In Vitro Studies and Mechanistic Evaluation.
    Bi YA; Lin J; Mathialagan S; Tylaska L; Callegari E; Rodrigues AD; Varma MVS
    Mol Pharm; 2018 Mar; 15(3):1284-1295. PubMed ID: 29433307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of in vivo biliary clearance from the in vitro transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II monolayer expressing both rat organic anion transporting polypeptide 4 and multidrug resistance associated protein 2.
    Sasaki M; Suzuki H; Aoki J; Ito K; Meier PJ; Sugiyama Y
    Mol Pharmacol; 2004 Sep; 66(3):450-9. PubMed ID: 15322236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics.
    Khamdang S; Takeda M; Babu E; Noshiro R; Onozato ML; Tojo A; Enomoto A; Huang XL; Narikawa S; Anzai N; Piyachaturawat P; Endou H
    Eur J Pharmacol; 2003 Mar; 465(1-2):1-7. PubMed ID: 12650826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Counter-flow suggests transport of dantrolene and 5-OH dantrolene by the organic anion transporters 2 (OAT2) and 3 (OAT3).
    Burckhardt BC; Henjakovic M; Hagos Y; Burckhardt G
    Pflugers Arch; 2016 Nov; 468(11-12):1909-1918. PubMed ID: 27812757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pH Dependent but not P-gp Dependent Bidirectional Transport Study of S-propranolol: The Importance of Passive Diffusion.
    Zheng Y; Benet LZ; Okochi H; Chen X
    Pharm Res; 2015 Aug; 32(8):2516-26. PubMed ID: 25690341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased liver distribution of entecavir is related to down-regulation of Oat2/Oct1 and up-regulation of Mrp1/2/3/5 in rat liver fibrosis.
    Xu Q; Wang C; Liu Q; Meng Q; Sun H; Peng J; Sun P; Huo X; Liu K
    Eur J Pharm Sci; 2015 Apr; 71():73-9. PubMed ID: 25712368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender-specific and developmental influences on the expression of rat organic anion transporters.
    Buist SC; Cherrington NJ; Choudhuri S; Hartley DP; Klaassen CD
    J Pharmacol Exp Ther; 2002 Apr; 301(1):145-51. PubMed ID: 11907168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative Prediction of Human Renal Clearance and Drug-Drug Interactions of Organic Anion Transporter Substrates Using In Vitro Transport Data: A Relative Activity Factor Approach.
    Mathialagan S; Piotrowski MA; Tess DA; Feng B; Litchfield J; Varma MV
    Drug Metab Dispos; 2017 Apr; 45(4):409-417. PubMed ID: 28179375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.
    Kindla J; Müller F; Mieth M; Fromm MF; König J
    Drug Metab Dispos; 2011 Jun; 39(6):1047-53. PubMed ID: 21389119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II cell monolayer expressing both human organic anion-transporting polypeptide (OATP2/SLC21A6) and Multidrug resistance-associated protein 2 (MRP2/ABCC2).
    Sasaki M; Suzuki H; Ito K; Abe T; Sugiyama Y
    J Biol Chem; 2002 Feb; 277(8):6497-503. PubMed ID: 11748225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3.
    Misaka S; Knop J; Singer K; Hoier E; Keiser M; Müller F; Glaeser H; König J; Fromm MF
    Mol Pharm; 2016 Feb; 13(2):512-9. PubMed ID: 26702643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)].
    Xu G; Bhatnagar V; Wen G; Hamilton BA; Eraly SA; Nigam SK
    Kidney Int; 2005 Oct; 68(4):1491-9. PubMed ID: 16164626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of OAT2 (SLC22A7) in the cyclic nucleotide biokinetics of human erythrocytes.
    Sager G; Smaglyukova N; Fuskevaag OM
    J Cell Physiol; 2018 Aug; 233(8):5972-5980. PubMed ID: 29244191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developmentally regulated expression of organic ion transporters NKT (OAT1), OCT1, NLT (OAT2), and Roct.
    Pavlova A; Sakurai H; Leclercq B; Beier DR; Yu AS; Nigam SK
    Am J Physiol Renal Physiol; 2000 Apr; 278(4):F635-43. PubMed ID: 10751225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoplasmic reticulum transporter OAT2 regulates drug metabolism and interaction.
    Arakawa H; Ishida N; Nakatsuji T; Matsumoto N; Imamura R; Shengyu D; Araya K; Horike SI; Tanaka-Yachi R; Kasahara M; Yoshioka T; Sumida Y; Ohmiya H; Daikoku T; Wakayama T; Nakamura K; Fujita KI; Kato Y
    Biochem Pharmacol; 2024 Jul; 225():116322. PubMed ID: 38815630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
    Guo A; Marinaro W; Hu P; Sinko PJ
    Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.